Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v2.4.0.8
Condensed Statements of Cash Flows (Unaudited) (USD $)
 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income $ 1,966,000 $ 2,854,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Amortization of Patents 668,000 7,000
Stock based compensation 326,000 223,000
Non-cash royalty revenue (70,000)   
Source (use) of cash from changes in operating assets and liabilities:    
Royalty receivables and other current assets (279,000) (596,000)
Accounts payable and accrued expenses (255,000) (1,052,000)
Income taxes payable and accrued expense (53,000) (54,000)
Deferred tax asset 192,000 709,000
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 2,495,000 2,091,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of patents and other assets (4,417,000)   
Investments (50,000)   
NET CASH USED IN INVESTING ACTIVITIES (4,467,000)   
CASH FLOWS FROM FINANCING ACTIVITIES:    
Value of shares delivered to fund withholding taxes (486,000) (487,000)
Repurchase of treasury stock (1,017,000) (52,000)
Proceeds from exercises of options and warrants 1,076,000   
NET CASH PROVIDED (USED IN) FINANCING ACTIVITIES (427,000) (539,000)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,399,000) 1,552,000
CASH AND CASH EQUIVALENTS, beginning of period 21,983,000 20,661,000
CASH AND CASH EQUIVALENTS, end of period 19,584,000  
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid during the periods for Interest      
Cash paid during the periods for Taxes 98,000 137,000
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Value of shares and warrants issued to purchase patents $ 1,617,000